Agreement dated September 25, 2017 between Resdevco Ltd. and Wize Pharma Ltd

EX-10.42 4 f8k111517ex10-42_wizepharma.htm AGREEMENT DATED SEPTEMBER 25, 2017 BETWEEN RESDEVCO LTD. AND WIZE PHARMA LTD

Exhibit 10.42





Commercialization Rights of LO2A in China


Resdevco Ltd. and Wize Pharma Ltd. hereby agree that Wize Pharma’s sole rights to commercialize LO2A in China, as declared in the letter from Resdevco, dated, September 6, 2017, shall be limited to one year if by September 6, 2018, Wize Pharma has not signed a distribution agreement of LO2A eye drops in China.


/s/ Prof. S. Dikstein   September 25, 2017
Resdevco Ltd   Date
/s/ Wize Pharma Ltd.   September 25, 2017
Wize Pharma Ltd.   Date






























P.O.B. 3338, Jerusalem, Israel

Tel. and Fax: 972-2 ###-###-####